CVSI

CV Sciences, Inc.

Price Chart

Latest Quote

$0.02

+0.00 (+0.00%)

Current Price

Previous Close	$0.02
Open	$0.02
Day High	$0.02
Day Low	$0.02
Volume	638,353

Fetched: 2026-06-18T19:49:12

Stock Information

Shares Outstanding	203.98M
Total Debt	$1.49M
Cash Equivalents	$309K
Revenue	$13.38M
Net Income	$-1.49M
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
Market Cap	$4.08M
EPS (TTM)	$-0.01
Exchange	OQB

🌐 Visit Website

📊 Comprehensive Analysis

Company Data

Enterprise Value	$4.47M
Sales	$13.38M
Income	$-1.49M
Book/sh	$0.01
Cash/sh	$0.00
Employees	42

Financial Ratios

Quick Ratio	0.14
Current Ratio	0.96
Debt/Eq	99.47

Returns & Margins

ROA	-6.90%
ROE	-88.02%
Gross Margin	49.75%
Operating Margin	-9.95%
Profit Margin	-11.15%

Ownership

Insider Ownership	7.79%
Insider & Institutional transactions data not available

Valuation Ratios

Forward P/E	-0.50
P/S	0.30
P/B	2.50

Analyst Data

Recommendation

none

Technical Indicators

SMA20	$0.03
SMA50	$0.03
SMA200	$0.04
ATR	0.0025

Shares Float	178.39M
Volatility	0.42
Rel Volume	0.95

Performance History

Week	-33.33%
Month	-33.33%
Quarter	-50.00%
6 Months	-33.33%
YTD	-66.67%
Year	-33.33%
3 Years	-50.00%
5 Years	-95.45%
10 Years	-95.12%

Stock Score: ⭐ Premium

Based on debt, profitability, growth, and cash flow metrics

⭐ Premium Feature

Recent Price History

Date	Close	Volume
2026-06-18	$0.02	638,353
2026-06-17	$0.02	2,348,000
2026-06-16	$0.02	2,428,600
2026-06-15	$0.02	524,000
2026-06-12	$0.02	1,118,500
2026-06-11	$0.03	314,000
2026-06-10	$0.03	659,400
2026-06-09	$0.03	117,100
2026-06-08	$0.03	69,200
2026-06-05	$0.03	16,000
2026-06-04	$0.03	42,700
2026-06-03	$0.03	308,600
2026-06-02	$0.03	173,700
2026-06-01	$0.03	155,600
2026-05-29	$0.03	610,600
2026-05-28	$0.03	1,002,800
2026-05-27	$0.03	1,658,200
2026-05-26	$0.03	444,400
2026-05-22	$0.03	655,900
2026-05-21	$0.03	172,100
2026-05-20	$0.03	283,500
2026-05-19	$0.03	74,400
2026-05-18	$0.03	139,300

About CV Sciences, Inc.

CV Sciences, Inc. engages in the development, manufacture, marketing, and sale of herbal supplements, hemp-based cannabidiol (CBD), and plant-based food products in North America. It offers its products under the PlusCBD, PlusCBD Pet, PlusHLTH, Cultured Foods, and Lunar Fox brand names in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, select distributors, brick and mortar retailers, and select e-tailers. The company was formerly known as CannaVest Corp. and changed its name to CV Sciences, Inc. in January 2016. CV Sciences, Inc. was incorporated in 2010 and is based in San Diego, California.

📰 Latest News

CV Sciences Inc (CVSI) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ...

GuruFocus.com • 2026-05-15T05:03:01Z

Trump expected to sign EO to reclassify marijuana as soon as Monday, CNBC says

TipRanks • 2025-12-13T16:15:27Z

CV Sciences Inc (CVSI) Q3 2025 Earnings Call Highlights: Navigating Challenges with Strategic ...

GuruFocus.com • 2025-11-14T05:03:04Z

Period:

Income Statement (Annual)

Metric	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue
Reconciled Cost Of Revenue	$8,537,000	$8,919,000	$10,655,000	$11,432,000
Cost Of Revenue	$8,537,000	$8,919,000	$10,655,000	$11,432,000
Total Revenue	$15,705,000	$16,004,000	$16,205,000	$20,048,000
Operating Revenue	$15,705,000	$16,004,000	$16,205,000	$20,048,000
Expenses
Total Expenses	$17,895,000	$12,644,000	$23,052,000	$38,494,000
Other Income Expense	$-212,000	$-264,000	$-1,414,000	$2,945,000
Other Non Operating Income Expenses	$-212,000	$-264,000	$-1,541,000	-
Operating Expense	$9,358,000	$3,725,000	$12,397,000	$27,062,000
Selling And Marketing Expense	$5,254,000	$6,005,000	$8,198,000	$11,945,000
General And Administrative Expense	$3,986,000	$3,740,000	$3,892,000	$13,932,000
Other Operating Expenses	-	$-6,171,000	-	-
Interest Expense	-	-	$1,541,000	$140,000
Net Non Operating Interest Income Expense	-	-	$-1,541,000	$-140,000
Interest Expense Non Operating	-	-	$1,541,000	$140,000
Income & Earnings
Net Income From Continuing Operation Net Minority Interest	$-2,394,000	$3,102,000	$-8,214,000	$-15,554,000
Normalized Income	$-2,394,000	$3,102,000	$-8,340,277	$-18,490,165
Net Income From Continuing And Discontinued Operation	$-2,394,000	$3,102,000	$-8,214,000	$-15,554,000
Total Operating Income As Reported	$-2,190,000	$3,360,000	$-6,847,000	$-18,446,000
Net Income Common Stockholders	$-2,394,000	$3,102,000	$-9,134,000	$-15,554,000
Net Income	$-2,394,000	$3,102,000	$-8,214,000	$-15,554,000
Net Income Including Noncontrolling Interests	$-2,394,000	$3,102,000	$-8,214,000	$-15,554,000
Net Income Continuous Operations	$-2,394,000	$3,102,000	$-8,214,000	$-15,554,000
Pretax Income	$-2,402,000	$3,096,000	$-8,261,000	$-15,641,000
Operating Income	$-2,190,000	$3,360,000	$-6,847,000	$-18,446,000
Gross Profit	$7,168,000	$7,085,000	$5,550,000	$8,616,000
Special Income Charges	-	$0	$127,000	$2,945,000
Net Interest Income	-	-	$-1,541,000	$-140,000
Per Share
Diluted EPS	$-0.01	$0.02	$-0.07	$-0.14
Basic EPS	$-0.01	$0.02	$-0.07	$-0.14
Other
Tax Effect Of Unusual Items	$0	$0	$723	$8,835
Tax Rate For Calcs	$0	$0	$0	$0
Normalized EBITDA (Bullshit earnings)	$-1,856,000	$3,595,000	$-5,982,000	$-17,293,000
Reconciled Depreciation	$334,000	$235,000	$992,000	$1,153,000
EBITDA (Bullshit earnings)	$-1,856,000	$3,595,000	$-5,855,000	$-14,348,000
EBIT	$-2,190,000	$3,360,000	$-6,847,000	$-15,501,000
Diluted Average Shares	$175,585,000	$153,955,000	$138,034,000	$107,817,000
Basic Average Shares	$175,585,000	$153,954,000	$138,034,000	$107,817,000
Diluted NI Availto Com Stockholders	$-2,394,000	$3,102,000	$-9,134,000	$-15,554,000
Tax Provision	$-8,000	$-6,000	$-47,000	$-87,000
Other Taxes	$0	$-6,171,000	$0	-
Research And Development	$118,000	$151,000	$307,000	$1,185,000
Selling General And Administration	$9,240,000	$9,745,000	$12,090,000	$25,877,000
Other Gand A	$3,986,000	$3,740,000	$3,892,000	$13,932,000
Total Unusual Items	-	$0	$127,000	$2,945,000
Total Unusual Items Excluding Goodwill	-	$0	$127,000	$2,945,000
Preferred Stock Dividends	-	-	$920,000	-
Other Special Charges	-	-	$-127,000	$-2,945,000

Fetched: 2026-02-02

Balance Sheet (Annual)

Metric	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Assets
Net Tangible Assets	$731,000	$2,483,000	$-1,028,000	$2,058,000
Total Assets	$7,927,000	$9,200,000	$12,736,000	$18,066,000
Total Non Current Assets	$1,685,000	$1,262,000	$1,606,000	$3,880,000
Other Non Current Assets	$127,000	$296,000	$505,000	$678,000
Goodwill And Other Intangible Assets	$1,064,000	$420,000	$251,000	$1,485,000
Other Intangible Assets	$93,000	$78,000	$251,000	$1,485,000
Current Assets	$6,243,000	$7,938,000	$11,130,000	$14,186,000
Other Current Assets	$370,000	$535,000	$3,190,000	$2,146,000
Inventory	$4,897,000	$5,655,000	$6,563,000	$8,624,000
Receivables	$522,000	$431,000	$766,000	$2,041,000
Accounts Receivable	$522,000	$431,000	$766,000	$2,041,000
Cash Cash Equivalents And Short Term Investments	$454,000	$1,317,000	$611,000	$1,375,000
Cash And Cash Equivalents	$454,000	$1,317,000	$611,000	$1,375,000
Cash Financial	$454,000	$1,317,000	$611,000	$1,375,000
Allowance For Doubtful Accounts Receivable	-	-	$-400,000	$-500,000
Gross Accounts Receivable	-	-	$1,166,000	$2,541,000
Restricted Cash	-	-	-	$0
Prepaid Assets	-	-	-	$2,146,000
Debt
Net Debt	$223,000	-	$612,000	-
Total Debt	$779,000	$442,000	$1,528,000	$922,000
Long Term Debt And Capital Lease Obligation	$19,000	$58,000	$188,000	$0
Current Debt And Capital Lease Obligation	$760,000	$384,000	$1,340,000	$922,000
Current Debt	$677,000	$254,000	$1,223,000	$922,000
Other Current Borrowings	$139,000	$204,000	$218,000	$922,000
Liabilities
Total Liabilities Net Minority Interest	$6,132,000	$6,297,000	$13,513,000	$14,523,000
Total Non Current Liabilities Net Minority Interest	$23,000	$182,000	$199,000	$62,000
Non Current Deferred Liabilities	$4,000	$19,000	$11,000	$62,000
Non Current Deferred Taxes Liabilities	$4,000	$19,000	$11,000	$62,000
Current Liabilities	$6,109,000	$6,115,000	$13,314,000	$14,461,000
Current Notes Payable	$538,000	$50,000	$1,005,000	$0
Payables And Accrued Expenses	$5,349,000	$5,731,000	$11,974,000	$13,539,000
Payables	$2,447,000	$2,831,000	$8,978,000	$9,318,000
Total Tax Payable	$522,000	$522,000	$6,694,000	$6,694,000
Accounts Payable	$1,925,000	$2,309,000	$2,284,000	$2,624,000
Other Non Current Liabilities	-	$105,000	-	-
Equity
Common Stock Equity	$1,795,000	$2,903,000	$-777,000	$3,543,000
Total Equity Gross Minority Interest	$1,795,000	$2,903,000	$-777,000	$3,543,000
Stockholders Equity	$1,795,000	$2,903,000	$-777,000	$3,543,000
Gains Losses Not Affecting Retained Earnings	$-15,000	$10,000	$0	-
Other Equity Adjustments	$-15,000	$10,000	-	-
Retained Earnings	$-86,981,000	$-84,587,000	$-87,689,000	$-79,475,000
Other
Ordinary Shares Number	$184,263,663	$161,679,059	$152,104,000	$112,482,000
Share Issued	$184,263,663	$161,679,059	$152,104,000	$112,482,000
Tangible Book Value	$731,000	$2,483,000	$-1,028,000	$2,058,000
Invested Capital	$2,472,000	$3,157,000	$446,000	$4,465,000
Working Capital	$134,000	$1,823,000	$-2,184,000	$-275,000
Capital Lease Obligations	$102,000	$188,000	$305,000	$0
Total Capitalization	$1,795,000	$2,903,000	$-777,000	$3,543,000
Additional Paid In Capital	$88,773,000	$87,464,000	$86,897,000	$83,007,000
Capital Stock	$18,000	$16,000	$15,000	$11,000
Common Stock	$18,000	$16,000	$15,000	$11,000
Preferred Stock	$0	$0	$0	$0
Long Term Capital Lease Obligation	$19,000	$58,000	$188,000	$0
Current Capital Lease Obligation	$83,000	$130,000	$117,000	$0
Current Accrued Expenses	$2,902,000	$2,900,000	$2,996,000	$4,221,000
Goodwill	$971,000	$342,000	$0	$0
Net PPE	$494,000	$546,000	$850,000	$1,717,000
Accumulated Depreciation	$-1,364,000	$-1,051,000	$-817,000	$-3,533,000
Gross PPE	$1,858,000	$1,597,000	$1,667,000	$5,250,000
Leases	$78,000	$0	$0	$1,967,000
Construction In Progress	$10,000	$0	-	$0
Other Properties	$94,000	$167,000	$275,000	$691,000
Machinery Furniture Equipment	$1,676,000	$1,430,000	$1,392,000	$2,592,000
Properties	$0	$0	$0	$0
Finished Goods	$1,667,000	$1,582,000	$1,980,000	$3,315,000
Work In Process	$649,000	$1,181,000	$1,020,000	$1,286,000
Raw Materials	$2,581,000	$2,892,000	$3,563,000	$4,023,000

Fetched: 2026-02-02

Cash Flow Statement (Annual)

Metric	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Free Cash Flow
Free Cash Flow	$-879,000	$2,253,000	$-1,885,000	$-7,520,000
Operating Activities
Operating Cash Flow	$-861,000	$2,253,000	$-1,885,000	$-7,485,000
Cash Flow From Continuing Operating Activities	$-861,000	$2,253,000	$-1,885,000	$-7,485,000
Operating Gains Losses	-	-	$-2,493,000	$-2,920,000
Investing Activities
Capital Expenditure	$-18,000	-	-	$-35,000
Investing Cash Flow	$-28,000	$-156,000	$0	$-35,000
Cash Flow From Continuing Investing Activities	$-28,000	$-156,000	$0	$-35,000
Financing Activities
Financing Cash Flow	$32,000	$-1,391,000	$1,121,000	$4,370,000
Cash Flow From Continuing Financing Activities	$32,000	$-1,391,000	$1,121,000	$4,370,000
Net Other Financing Charges	$-5,000	-	$-615,000	$-229,000
Issuance Of Capital Stock	-	$0	$700,000	$4,407,000
Net Preferred Stock Issuance	-	$0	$700,000	$0
Preferred Stock Issuance	-	$0	$700,000	$0
Net Common Stock Issuance	-	-	$0	$4,407,000
Common Stock Issuance	-	-	$0	$4,407,000
Other
Repayment Of Debt	$-863,000	$-1,391,000	$-1,964,000	$-808,000
Issuance Of Debt	$900,000	$0	$3,000,000	$1,000,000
Interest Paid Supplemental Data	$8,000	$7,000	$6,000	$10,000
Income Tax Paid Supplemental Data	$6,000	$0	$2,000	$13,000
End Cash Position	$454,000	$1,317,000	$611,000	$1,375,000
Beginning Cash Position	$1,317,000	$611,000	$1,375,000	$4,525,000
Effect Of Exchange Rate Changes	$-6,000	$0	-	-
Changes In Cash	$-857,000	$706,000	$-764,000	$-3,150,000
Net Issuance Payments Of Debt	$37,000	$-1,391,000	$1,036,000	$192,000
Net Long Term Debt Issuance	$37,000	$-1,391,000	$1,036,000	$-808,000
Long Term Debt Payments	$-863,000	$-1,391,000	$-1,964,000	$-808,000
Long Term Debt Issuance	$900,000	$0	$3,000,000	$0
Net Business Purchase And Sale	$-10,000	$-156,000	$0	-
Purchase Of Business	$-10,000	$-156,000	$0	-
Net PPE Purchase And Sale	$-18,000	$0	$0	$-35,000
Purchase Of PPE	$-18,000	$0	$0	$-35,000
Change In Working Capital	$458,000	$4,005,000	$3,556,000	$1,916,000
Change In Payables And Accrued Expense	$-603,000	$-320,000	$-1,250,000	$1,644,000
Change In Prepaid Assets	$342,000	$2,931,000	$1,680,000	$1,045,000
Change In Inventory	$803,000	$1,042,000	$2,061,000	$216,000
Change In Receivables	$-84,000	$352,000	$1,065,000	$-989,000
Changes In Account Receivables	$-84,000	$352,000	$1,065,000	$-989,000
Other Non Cash Items	$498,000	$627,000	$2,082,000	$-303,000
Stock Based Compensation	$258,000	$218,000	$1,009,000	$3,210,000
Asset Impairment Charge	$0	$251,000	$1,234,000	$5,107,000
Deferred Tax	$-15,000	$-6,185,000	$-51,000	$-94,000
Deferred Income Tax	$-15,000	$-6,185,000	$-51,000	$-94,000
Depreciation Amortization Depletion	$334,000	$235,000	$992,000	$1,153,000
Depreciation And Amortization	$334,000	$235,000	$992,000	$1,153,000
Depreciation	$334,000	$235,000	$992,000	$1,153,000
Net Income From Continuing Operations	$-2,394,000	$3,102,000	$-8,214,000	$-15,554,000
Pension And Employee Benefit Expense	-	$0	$-2,516,000	$0
Gain Loss On Sale Of PPE	-	$0	$150,000	$25,000
Net Short Term Debt Issuance	-	-	$325,000	$1,000,000
Short Term Debt Payments	-	-	$-675,000	$0
Short Term Debt Issuance	-	-	$1,000,000	$1,000,000
Change In Payable	-	-	$-1,250,000	$1,644,000
Change In Account Payable	-	-	$-1,250,000	$1,644,000
Proceeds From Stock Option Exercised	-	-	-	$0

Fetched: 2026-02-02